Cargando…
Outpatient hydroxychloroquine prescribing at a large academic health system during the COVID-19 pandemic
Autores principales: | Ha, David R., Kuo, Jamie, Aung, Phyo S., Chang, Tiffany, Witt, Lana G., Alegria, William, Chang, Amy, Meng, Lina, Deresinski, Stanley P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253767/ https://www.ncbi.nlm.nih.gov/pubmed/32412404 http://dx.doi.org/10.1017/ice.2020.243 |
Ejemplares similares
-
Sustained Reduction in Urgent Care Antibiotic Prescribing During the Coronavirus Disease 2019 Pandemic: An Academic Medical Center’s Experience
por: Ha, David, et al.
Publicado: (2022) -
1489. Safety and Performance of a Pharmacist-Driven Nasal MRSA PCR Protocol for De-escalation of Empiric Vancomycin for Suspected Pneumonia at an Academic Medical Center
por: Meng, Lina, et al.
Publicado: (2020) -
Association Between US Administration Endorsement of Hydroxychloroquine for COVID-19 and Outpatient Prescribing
por: Harrigan, James J., et al.
Publicado: (2020) -
Risk factors and outcomes associated with persistent vancomycin resistant Enterococcal Bacteremia
por: Fox, Emily, et al.
Publicado: (2022) -
Decreased antimicrobial prescribing rate following academic detailing of resident physicians in outpatient clinic
por: Andrews, Shannon L., et al.
Publicado: (2023)